 | • レポートコード：QYR2104Z5356 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ソフトカプセル治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（液体コアドラッグ、半固体コアドラッグ）、用途別市場規模（病院薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ソフトカプセル治療薬の市場動向 ・企業の競争状況、市場シェア ・ソフトカプセル治療薬の種類別市場規模（液体コアドラッグ、半固体コアドラッグ） ・ソフトカプセル治療薬の用途別市場規模（病院薬局、小売薬局） ・ソフトカプセル治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ソフトカプセル治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ソフトカプセル治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ソフトカプセル治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ソフトカプセル治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、AstraZeneca、Boehringer Ingelheim、Vertex、Roche、Novartis、Teva、Chiesi、Sumitomo Dainippon、Merck、Atrium Innovations、Abbott、Blackmores、The Clorox Company、Nature Made、By-health、A&Z Pharmaceutical） ・結論 |
Soft gel capsules are typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety of medicines, including complementary medicines, such as vitamins. In some cases, these medicines may have directions for use that say that they can or should be chewed.
Market Analysis and Insights: Global Soft Capsules Drugs Market
The global Soft Capsules Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Soft Capsules Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Soft Capsules Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Soft Capsules Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Soft Capsules Drugs market.
Global Soft Capsules Drugs Scope and Market Size
Soft Capsules Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Soft Capsules Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Liquid Core Drugs
Semi-solid Core Drugs
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Sumitomo Dainippon
Vertex
Roche
Abbott
Blackmores
The Clorox Company
Nature Made
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Capsules Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liquid Core Drugs
1.2.3 Semi-solid Core Drugs
1.3 Market by Application
1.3.1 Global Soft Capsules Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Soft Capsules Drugs Market Perspective (2016-2027)
2.2 Soft Capsules Drugs Growth Trends by Regions
2.2.1 Soft Capsules Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Soft Capsules Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Soft Capsules Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Soft Capsules Drugs Industry Dynamic
2.3.1 Soft Capsules Drugs Market Trends
2.3.2 Soft Capsules Drugs Market Drivers
2.3.3 Soft Capsules Drugs Market Challenges
2.3.4 Soft Capsules Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Soft Capsules Drugs Players by Revenue
3.1.1 Global Top Soft Capsules Drugs Players by Revenue (2016-2021)
3.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Soft Capsules Drugs Revenue
3.4 Global Soft Capsules Drugs Market Concentration Ratio
3.4.1 Global Soft Capsules Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs Revenue in 2020
3.5 Soft Capsules Drugs Key Players Head office and Area Served
3.6 Key Players Soft Capsules Drugs Product Solution and Service
3.7 Date of Enter into Soft Capsules Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Soft Capsules Drugs Breakdown Data by Type
4.1 Global Soft Capsules Drugs Historic Market Size by Type (2016-2021)
4.2 Global Soft Capsules Drugs Forecasted Market Size by Type (2022-2027)
5 Soft Capsules Drugs Breakdown Data by Application
5.1 Global Soft Capsules Drugs Historic Market Size by Application (2016-2021)
5.2 Global Soft Capsules Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Soft Capsules Drugs Market Size (2016-2027)
6.2 North America Soft Capsules Drugs Market Size by Type
6.2.1 North America Soft Capsules Drugs Market Size by Type (2016-2021)
6.2.2 North America Soft Capsules Drugs Market Size by Type (2022-2027)
6.2.3 North America Soft Capsules Drugs Market Size by Type (2016-2027)
6.3 North America Soft Capsules Drugs Market Size by Application
6.3.1 North America Soft Capsules Drugs Market Size by Application (2016-2021)
6.3.2 North America Soft Capsules Drugs Market Size by Application (2022-2027)
6.3.3 North America Soft Capsules Drugs Market Size by Application (2016-2027)
6.4 North America Soft Capsules Drugs Market Size by Country
6.4.1 North America Soft Capsules Drugs Market Size by Country (2016-2021)
6.4.2 North America Soft Capsules Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Soft Capsules Drugs Market Size (2016-2027)
7.2 Europe Soft Capsules Drugs Market Size by Type
7.2.1 Europe Soft Capsules Drugs Market Size by Type (2016-2021)
7.2.2 Europe Soft Capsules Drugs Market Size by Type (2022-2027)
7.2.3 Europe Soft Capsules Drugs Market Size by Type (2016-2027)
7.3 Europe Soft Capsules Drugs Market Size by Application
7.3.1 Europe Soft Capsules Drugs Market Size by Application (2016-2021)
7.3.2 Europe Soft Capsules Drugs Market Size by Application (2022-2027)
7.3.3 Europe Soft Capsules Drugs Market Size by Application (2016-2027)
7.4 Europe Soft Capsules Drugs Market Size by Country
7.4.1 Europe Soft Capsules Drugs Market Size by Country (2016-2021)
7.4.2 Europe Soft Capsules Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Soft Capsules Drugs Market Size (2016-2027)
8.2 Asia-Pacific Soft Capsules Drugs Market Size by Type
8.2.1 Asia-Pacific Soft Capsules Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Soft Capsules Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Soft Capsules Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Soft Capsules Drugs Market Size by Application
8.3.1 Asia-Pacific Soft Capsules Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Soft Capsules Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Soft Capsules Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Soft Capsules Drugs Market Size by Region
8.4.1 Asia-Pacific Soft Capsules Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Soft Capsules Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Soft Capsules Drugs Market Size (2016-2027)
9.2 Latin America Soft Capsules Drugs Market Size by Type
9.2.1 Latin America Soft Capsules Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Soft Capsules Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Soft Capsules Drugs Market Size by Type (2016-2027)
9.3 Latin America Soft Capsules Drugs Market Size by Application
9.3.1 Latin America Soft Capsules Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Soft Capsules Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Soft Capsules Drugs Market Size by Application (2016-2027)
9.4 Latin America Soft Capsules Drugs Market Size by Country
9.4.1 Latin America Soft Capsules Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Soft Capsules Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Soft Capsules Drugs Market Size (2016-2027)
10.2 Middle East & Africa Soft Capsules Drugs Market Size by Type
10.2.1 Middle East & Africa Soft Capsules Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Soft Capsules Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Soft Capsules Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Soft Capsules Drugs Market Size by Application
10.3.1 Middle East & Africa Soft Capsules Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Soft Capsules Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Soft Capsules Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Soft Capsules Drugs Market Size by Country
10.4.1 Middle East & Africa Soft Capsules Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Soft Capsules Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Soft Capsules Drugs Introduction
11.1.4 GSK Revenue in Soft Capsules Drugs Business (2016-2021)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Soft Capsules Drugs Introduction
11.2.4 AstraZeneca Revenue in Soft Capsules Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Soft Capsules Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Details
11.4.2 Vertex Business Overview
11.4.3 Vertex Soft Capsules Drugs Introduction
11.4.4 Vertex Revenue in Soft Capsules Drugs Business (2016-2021)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Soft Capsules Drugs Introduction
11.5.4 Roche Revenue in Soft Capsules Drugs Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Soft Capsules Drugs Introduction
11.6.4 Novartis Revenue in Soft Capsules Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Soft Capsules Drugs Introduction
11.7.4 Teva Revenue in Soft Capsules Drugs Business (2016-2021)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Details
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Soft Capsules Drugs Introduction
11.8.4 Chiesi Revenue in Soft Capsules Drugs Business (2016-2021)
11.8.5 Chiesi Recent Development
11.9 Sumitomo Dainippon
11.9.1 Sumitomo Dainippon Company Details
11.9.2 Sumitomo Dainippon Business Overview
11.9.3 Sumitomo Dainippon Soft Capsules Drugs Introduction
11.9.4 Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2016-2021)
11.9.5 Sumitomo Dainippon Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Soft Capsules Drugs Introduction
11.10.4 Merck Revenue in Soft Capsules Drugs Business (2016-2021)
11.10.5 Merck Recent Development
11.11 Atrium Innovations
11.11.1 Atrium Innovations Company Details
11.11.2 Atrium Innovations Business Overview
11.11.3 Atrium Innovations Soft Capsules Drugs Introduction
11.11.4 Atrium Innovations Revenue in Soft Capsules Drugs Business (2016-2021)
11.11.5 Atrium Innovations Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Soft Capsules Drugs Introduction
11.12.4 Abbott Revenue in Soft Capsules Drugs Business (2016-2021)
11.12.5 Abbott Recent Development
11.13 Blackmores
11.13.1 Blackmores Company Details
11.13.2 Blackmores Business Overview
11.13.3 Blackmores Soft Capsules Drugs Introduction
11.13.4 Blackmores Revenue in Soft Capsules Drugs Business (2016-2021)
11.13.5 Blackmores Recent Development
11.14 The Clorox Company
11.14.1 The Clorox Company Company Details
11.14.2 The Clorox Company Business Overview
11.14.3 The Clorox Company Soft Capsules Drugs Introduction
11.14.4 The Clorox Company Revenue in Soft Capsules Drugs Business (2016-2021)
11.14.5 The Clorox Company Recent Development
11.15 Nature Made
11.15.1 Nature Made Company Details
11.15.2 Nature Made Business Overview
11.15.3 Nature Made Soft Capsules Drugs Introduction
11.15.4 Nature Made Revenue in Soft Capsules Drugs Business (2016-2021)
11.15.5 Nature Made Recent Development
11.16 By-health
11.16.1 By-health Company Details
11.16.2 By-health Business Overview
11.16.3 By-health Soft Capsules Drugs Introduction
11.16.4 By-health Revenue in Soft Capsules Drugs Business (2016-2021)
11.16.5 By-health Recent Development
11.17 A&Z Pharmaceutical
11.17.1 A&Z Pharmaceutical Company Details
11.17.2 A&Z Pharmaceutical Business Overview
11.17.3 A&Z Pharmaceutical Soft Capsules Drugs Introduction
11.17.4 A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2016-2021)
11.17.5 A&Z Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Soft Capsules Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liquid Core Drugs
Table 3. Key Players of Semi-solid Core Drugs
Table 4. Global Soft Capsules Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Soft Capsules Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Soft Capsules Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Soft Capsules Drugs Market Share by Regions (2016-2021)
Table 8. Global Soft Capsules Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Soft Capsules Drugs Market Share by Regions (2022-2027)
Table 10. Soft Capsules Drugs Market Trends
Table 11. Soft Capsules Drugs Market Drivers
Table 12. Soft Capsules Drugs Market Challenges
Table 13. Soft Capsules Drugs Market Restraints
Table 14. Global Soft Capsules Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Soft Capsules Drugs Market Share by Players (2016-2021)
Table 16. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Capsules Drugs as of 2020)
Table 17. Ranking of Global Top Soft Capsules Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Soft Capsules Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Soft Capsules Drugs Product Solution and Service
Table 21. Date of Enter into Soft Capsules Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Soft Capsules Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Soft Capsules Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Soft Capsules Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Soft Capsules Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Soft Capsules Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Soft Capsules Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Soft Capsules Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Soft Capsules Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Soft Capsules Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Soft Capsules Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Soft Capsules Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Soft Capsules Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Soft Capsules Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Soft Capsules Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Soft Capsules Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Soft Capsules Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Soft Capsules Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Soft Capsules Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Soft Capsules Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Soft Capsules Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Soft Capsules Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Soft Capsules Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Soft Capsules Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Soft Capsules Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Soft Capsules Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Soft Capsules Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Soft Capsules Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Soft Capsules Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Soft Capsules Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Soft Capsules Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Soft Capsules Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Soft Capsules Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Soft Capsules Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Soft Capsules Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Soft Capsules Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Soft Capsules Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Soft Capsules Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Soft Capsules Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. GSK Company Details
Table 62. GSK Business Overview
Table 63. GSK Soft Capsules Drugs Product
Table 64. GSK Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 65. GSK Recent Development
Table 66. AstraZeneca Company Details
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Soft Capsules Drugs Product
Table 69. AstraZeneca Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. Boehringer Ingelheim Company Details
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim Soft Capsules Drugs Product
Table 74. Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. Vertex Company Details
Table 77. Vertex Business Overview
Table 78. Vertex Soft Capsules Drugs Product
Table 79. Vertex Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 80. Vertex Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Soft Capsules Drugs Product
Table 84. Roche Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Soft Capsules Drugs Product
Table 89. Novartis Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Teva Company Details
Table 92. Teva Business Overview
Table 93. Teva Soft Capsules Drugs Product
Table 94. Teva Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 95. Teva Recent Development
Table 96. Chiesi Company Details
Table 97. Chiesi Business Overview
Table 98. Chiesi Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 99. Chiesi Recent Development
Table 100. Sumitomo Dainippon Company Details
Table 101. Sumitomo Dainippon Business Overview
Table 102. Sumitomo Dainippon Soft Capsules Drugs Product
Table 103. Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 104. Sumitomo Dainippon Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Soft Capsules Drugs Product
Table 108. Merck Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 109. Merck Recent Development
Table 110. Atrium Innovations Company Details
Table 111. Atrium Innovations Business Overview
Table 112. Atrium Innovations Soft Capsules Drugs Product
Table 113. Atrium Innovations Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 114. Atrium Innovations Recent Development
Table 115. Abbott Company Details
Table 116. Abbott Business Overview
Table 117. Abbott Soft Capsules Drugs Product
Table 118. Abbott Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 119. Abbott Recent Development
Table 120. Blackmores Company Details
Table 121. Blackmores Business Overview
Table 122. Blackmores Soft Capsules Drugs Product
Table 123. Blackmores Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 124. Blackmores Recent Development
Table 125. The Clorox Company Company Details
Table 126. The Clorox Company Business Overview
Table 127. The Clorox Company Soft Capsules Drugs Product
Table 128. The Clorox Company Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 129. The Clorox Company Recent Development
Table 130. Nature Made Company Details
Table 131. Nature Made Business Overview
Table 132. Nature Made Soft Capsules Drugs Product
Table 133. Nature Made Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 134. Nature Made Recent Development
Table 135. By-health Company Details
Table 136. By-health Business Overview
Table 137. By-health Soft Capsules Drugs Product
Table 138. By-health Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 139. By-health Recent Development
Table 140. A&Z Pharmaceutical Company Details
Table 141. A&Z Pharmaceutical Business Overview
Table 142. A&Z Pharmaceutical Soft Capsules Drugs Product
Table 143. A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2016-2021) & (US$ Million)
Table 144. A&Z Pharmaceutical Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Soft Capsules Drugs Market Share by Type: 2020 VS 2027
Figure 2. Liquid Core Drugs Features
Figure 3. Semi-solid Core Drugs Features
Figure 4. Global Soft Capsules Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Soft Capsules Drugs Report Years Considered
Figure 8. Global Soft Capsules Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Soft Capsules Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Soft Capsules Drugs Market Share by Regions: 2020 VS 2027
Figure 11. Global Soft Capsules Drugs Market Share by Regions (2022-2027)
Figure 12. Global Soft Capsules Drugs Market Share by Players in 2020
Figure 13. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Capsules Drugs as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Soft Capsules Drugs Revenue in 2020
Figure 15. Global Soft Capsules Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Global Soft Capsules Drugs Revenue Market Share by Type (2022-2027)
Figure 17. North America Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Soft Capsules Drugs Market Share by Type (2016-2027)
Figure 19. North America Soft Capsules Drugs Market Share by Application (2016-2027)
Figure 20. North America Soft Capsules Drugs Market Share by Country (2016-2027)
Figure 21. United States Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Soft Capsules Drugs Market Share by Type (2016-2027)
Figure 25. Europe Soft Capsules Drugs Market Share by Application (2016-2027)
Figure 26. Europe Soft Capsules Drugs Market Share by Country (2016-2027)
Figure 27. Germany Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Soft Capsules Drugs Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Soft Capsules Drugs Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Soft Capsules Drugs Market Share by Region (2016-2027)
Figure 37. China Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Soft Capsules Drugs Market Share by Type (2016-2027)
Figure 45. Latin America Soft Capsules Drugs Market Share by Application (2016-2027)
Figure 46. Latin America Soft Capsules Drugs Market Share by Country (2016-2027)
Figure 47. Mexico Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Soft Capsules Drugs Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Soft Capsules Drugs Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Soft Capsules Drugs Market Share by Country (2016-2027)
Figure 53. Turkey Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Soft Capsules Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. GSK Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 57. AstraZeneca Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 59. Vertex Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 62. Teva Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 63. Chiesi Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 64. Sumitomo Dainippon Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 66. Atrium Innovations Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 67. Abbott Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 68. Blackmores Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 69. The Clorox Company Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 70. Nature Made Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 71. By-health Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 72. A&Z Pharmaceutical Revenue Growth Rate in Soft Capsules Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のソフトカプセル医薬品CMO市場規模・現状・予測（2021年-2027年） The company supply Softgel Capsule contract pharmaceutical manufacturing services Market Analysis and Insights: Global Soft Capsules Drugs CMO Market The global Soft Capsules Drugs CMO market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021…- 世界の植物・植物由来薬剤市場規模・現状・予測（2021年-2027年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- 世界のコリン作動薬市場規模・現状・予測（2021年-2027年） Cholinergic drug, any of various drugs that inhibit, enhance, or mimic the action of the neurotransmitter acetylcholine, the primary transmitter of nerve impulses within the parasympathetic nervous system. Market Analysis and Insights: Global Cholinergic Drugs Market The global Cholinergic Drugs mar…
- 世界のOTC外用薬市場規模・現状・予測（2021年-2027年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 世界のイロプロスト薬市場規模・現状・予測（2021年-2027年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. North America is estimated to have a major share in the global market with 75%. Market Analysis…